Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.59 |
| ▸ | CCR2 | P41597 | 1/20 | 0.59 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.49 |
| ▸ | EDNRB | P24530 | 1/20 | 0.49 |
| ▸ | EDNRA | P25101 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6599266 | 0.85 | ABCB11 (0.77) | ABCB11CCR2KDM4ELMNAGAA | |
| SCHEMBL5216231 | 0.82 | ABCB11 (0.52) | ABCB11CCR2PLA2G2AKDM4ELMNA | |
| SCHEMBL5214261 | 0.81 | ABCB11 (0.51) | ABCB11CCR2PLA2G2AKDM4ELMNA | |
| SCHEMBL6856097 | 0.79 | PLA2G2A (0.63) | PLA2G2AEDNRBEDNRA | |
| SCHEMBL6851293 | 0.78 | KDM4E (0.53) | PLA2G2AEDNRBEDNRAKDM4ELMNA | |
| SCHEMBL9538311 | 0.78 | CCR2 (0.60) | CCR2PLA2G2AEDNRBEDNRAKDM4E | |
| SCHEMBL21465462 | 0.77 | ABCB11 (0.52) | ABCB11CCR2PLA2G2AKDM4ELMNA | |
| SCHEMBL5214735 | 0.75 | CCR2 (0.54) | ABCB11CCR2KDM4ELMNAGAA | |
| SCHEMBL6858271 | 0.75 | EDNRB (0.55) | PLA2G2AEDNRBEDNRAKDM4ELMNA | |
| SCHEMBL5214863 | 0.75 | CCR2 (0.76) | ABCB11CCR2KDM4ELMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1150952-B1 | INDOLE DERIVATIVES AND THEIR USE AS MCP-1 RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2004-10-27 | — | — | EP | disclosed |
| US-6737435-B1 | ANTIINFLAMMATORY AGENTS; MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) DISEASES | ASTRAZENECA AB (SE) | 2004-05-18 | — | — | US | disclosed |
| EP-1150952-A1 | INDOLE DERIVATIVES AND THEIR USE AS MCP-1 RECEPTOR ANTAGONISTS | AstraZeneca AB (SE) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000046196-A1 | INDOLE DERIVATIVES AND THEIR USE AS MCP-1 ANTAGONISTS | ASTRAZENECA AB (SE) | 2000-08-10 | — | — | WO | disclosed |